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Abstract
Hesperetin dihydrochalcone 4′-glucoside, 1 and phloretin 4′-glucoside, 2 belong to a family of 
dihydrochalcone glycosides that exhibit flavorant properties. We have developed a competitive, 
indirect homologous ELISA for the detection of targets 1 and 2 in fermentation media. 
Immunogen and coating antigen were prepared by conjugating hapten, 4-(3-oxo-3-(2,6-
dihydroxy-4-glucoside phenyl)propyl) benzoic acid to thyroglobulin and bovine serum albumin, 
respectively. Antibodies raised in rabbits M6122, M6123 and M6124 and the coating antigen were 
screened and characterized to determine their optimum concentrations. The optimized ELISA, 
developed with antibody M6122, gave IC50 values of 27.8 and 21.8 ng/mL for 1 and 2, 
respectively. Selectivity of the assay was assessed by measuring cross-reactivity of antibody 
M6122 to related congeners such as aglycones and the 2′-glycosides of hesperetin 
dihydrochalcone, 5 and phloretin, 6. Antibody M6122 showed very low recognition of 5 and 
virtually no recognition of the aglycones and 6.
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INTRODUCTION
Flavonoids1,2,3,4,5 are a large and diverse group of polyphenol compounds. They are present 
in many plants. Flavonoid patterns are normally characteristic of individual plants. They 
often are ubiquitous in leaves, stems, roots and fruits, and thus form an important part of the 
human diet. Structurally, they contain a fifteen carbon atom core, with a chroman ring (rings 
A and C) coupled to a second phenyl ring (ring B) through its C2, C3 or C4 position. Figure 
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1 depicts the structure of a citrus flavanone, neohesperidin as an example. Some of these 
compounds exhibit taste properties. One of the most active areas of flavonoid research is on 
their beneficial health effects, especially their antioxidant activities. The high antioxidant 
activity of some flavonoids is attributed to the presence of specific structural synthons that 
drive the inhibition of lipid peroxidation, as evidenced by in vitro analyses.6,7 
Epidemiological studies point to an inverse relationship between dietary flavonoid intake 
and incidence of coronary heart disease8, explained by their inhibitory effects on free radical 
oxidation of low-density lipids.9 They act as natural ultraviolet radiation filters, by 
scavenging oxygen free radicals generated by UV irradiation.10 Some phenolics can serve as 
good topical photo-protective agents. Hydroxyflavones are well-known for their broad-
spectrum antimicrobial function11 that aids in not only protecting plant life, but is also 
useful for the treatment of human diseases. One notable example is 5,6,7-trihydroxyflavone 
7-glucuronide (baicalin), that has an inhibitory effect on the human immunodeficiency virus 
(HIV).12
Dihydrochalcones13 are a sub-class of flavonoids. The unique feature that distinguishes the 
dihydrochalcones from other flavonoids is the open-chain three-carbon structure linking the 
A- and B-rings in place of a heterocyclic C-ring (Table 1). This close structural correlation 
accounts for the co-occurrence of dihydrochalcones and flavanones as natural products. 
Dihydrochalcones are reported to exhibit a wide spectrum of bioactivities.14,15,16,17 Simple 
dihydrochalcones such as phloretin, phloridzin and the recently discovered sieboldin18 
possess anti-inflammatory and anti-hypertensive properties, and have important 
ramifications on cardiovascular disease and diabetes.19 Some dihydrochalcones and their 
glycosylated derivatives are found to be sweet. They are usually derived from bitter 
ingredients found in plants such as apple, citrus or tea leaves. Studies suggest a strong 
structure-“sweet” taste correlation for the dihydrochalcones.20
Hesperetin dihydrochlcone 4′-glucoside, 1 and phloretin 4′-glucoside, 2, also commonly 
referred to as trilobatin (Table 1) are dihydrochalcone glycosides that are capable of 
imparting sweetness to food products, when used at high levels, but to our knowledge are 
not currently used commercially for this purpose. The 4′-glucoside targets elicit interesting 
taste properties when used at levels below their detection threshold.21 There is an interest in 
the large-scale synthesis of the target compounds 1 and 2 by microbial fermentation. This 
synthetic procedure may also yield other structurally similar, but undesirable 
dihydrochalcones, such as the corresponding dihydrochalcone 2′-glycosides (5, 6) and the 
aglycones (3, 4). Therefore, there is a need for developing a rapid and accurate method for 
the exclusive detection and measurement of the target 4′-glucosides in the desired 
fermentation broth. Currently, the method used for the measurement of compounds 1 and 2 
is high-performance liquid chromatography (HPLC). Despite the HPLC method being 
sensitive and selective, limitations still exist; it is expensive, time-consuming and requires 
large quantities of solvent. In contrast, the enzyme-linked immunosorbent assay (ELISA) 
technique is a rapid, sensitive and cost- and time-effective tool, amenable to high-
throughput, on-site screening tests for process development.22 The assay will allow a “real-
time”, on-site detection and measurement of the targets, which will speed process 
optimization. The assay will be useful in two ways; one will be to test the fermentation 
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media in order to measure the levels of targets 1 and 2 being produced during pathway 
optimization and process development. The other use could be to screen large enzyme 
libraries for specificity of the glycosylation step during enzyme discovery or optimization to 
narrow the search for an appropriate enzyme to develop a process. To the best of our 
knowledge, a polyclonal antibody-based ELISA for detection of dihydrochalcone glycosides 
such as 1 and 2 has not been previously reported, except for a single report on the 
production of monoclonal antibodies for quercetin flavonoid glycoside and its corresponding 
glucuronide.23 Herein, we report the design and development of an indirect, homologous 




The hapten coupling reagents, bovine serum albumin (BSA), thyroglobulin (Thy), Tween 
20, 3,3′,5,5′-tetramethylbenzidine (TMB) were purchased from Sigma-Aldrich. Co. (St. 
Louis, MO). Goat anti-rabbit IgG peroxidase conjugate (GAR-HRP) was purchased from 
Abcam (Cambridge, MA). ELISA was performed on 96-well polystyrene microtiter plates 
(Nunc MaxiSorp, Roskilde, Denmark) and read spectrophotometrically with a microplate 
reader (Molecular Devices, Sunnyvale, CA) in dual wavelength mode (450-650 nm).
Buffers
All buffers were prepared with ultrapure deionized water. Phosphate buffered saline (1× 
PBS, pH 7.5), wash buffer (PBST): 1× PBS containing 0.05% Tween 20. Coating buffer (pH 
9.6): 15 mM Na2CO3, 34.88 mM NaHCO3, 3.08 mM NaN3. Blocking agent: 1% BSA-PBS. 
Substrate buffer (pH 5.5): 0.1 M sodium acetate/citrate buffer. For the substrate solution, 0.4 
mL of 0.6% TMB (in DMSO w/v) and 0.1 mL of 1% H2O2 were added to 25 mL sodium 
acetate-citrate buffer. Stop solution was 2N H2SO4.
Hapten Synthesis
Figure 1 depicts the structure of hapten 4-(3-oxo-3-(2,6-dihydroxy-4-glucoside phenyl) 
propyl)benzoic acid. The hapten was prepared by an enzyme-catalyzed (naringinase) 
reaction of 4-(3-oxo-3-(2,6-dihydroxy-4-neohesperidoside phenyl)propyl)benzoic acid. A 
jacketed flask equipped with a magnetic stirbar was equilibrated to 65 °C using a 
temperature controlled water circulator. To the flask was added a buffer solution (50 mL, 0.1 
M KH2PO4, 0.2 M Na2HPO4, pH = 6.6) and naringinase (1.5 g). The reaction was stirred for 
2 h at 65 °C. 4-(3-oxo-3-(2,6-dihydroxy-4-neohesperidoside phenyl)propyl)benzoic acid (1.2 
g, 0.002 mol) was dissolved in 10 mL of distilled water and added to the stirred reaction. 
The reaction was cooled to 45 °C with stirring for 24 h or until complete by TLC analysis 
(BuOH/PrOH/H2O, 10/5/4 (v/v)). The reaction was heated to 90 °C for 15 min to deactivate 
the enzyme. The enzyme was removed from the reaction solution by vacuum filtration. 
Purification was performed with HP-20 resin (0-60% MeOH in water) followed by HPLC 
(5-50% MeOH with 0.01% formic acid in water). Fractions were identified by NMR 
analysis and lyophilized to provide a light yellow powder (0.092 g, 9.9% yield). NMR 
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analysis provided an estimated 90% pure product which was deemed acceptable for use in 
this assay.
1H NMR (300 MHz, CD3OD): δ 7.86-7.84 (2H, d, J = 8.0 Hz), 7.26-7.23 (2H, d, J = 8.0 
Hz), 5.96 (2H, s), 4.94-4.91 (1H, d, J = 7.0 Hz), 3.91 (1H, d, J = 11.0 Hz), 3.76-3.73 (1H, 
m), 3.44-3.40 (4H, m), 3.32-3.30 (2H, q, J = 7.0 Hz, J = 1.5 Hz), 3.00-2.96 (2H, t, J = 15.0 
Hz, J = 7.5 Hz); 13C NMR (75 MHz, CD3OD): δ 206.22, 165.71, 164.98, 148.39, 148.23, 
130.81, 129.42, 106.82, 105.24, 101.12, 96.44, 78.23, 77.86, 74.60, 71.14, 64.36, 62.34, 
46.49, 31.76.
Preparation of Immunogen and Coating Antigen
The carbodiimide method24 was employed for activation of the carboxylic acid group in the 
hapten. The hapten was coupled to porcine thyroglobulin (as the immunizing antigen) and 
bovine serum albumin (as the coating antigen) using the N-hydroxysulfosuccinimide ester 
method. Hapten was dissolved (3 mg, 0.0065 mmol) in 0.9 mL of 0.1 M PIPES (piperazine-
N,N’-bis(2-ethanesulfonic acid)) buffer (pH 6.1). EDC, 1-ethyl-3-[3-
dimethylaminopropyl]carbodiimide hydrochloride, (1.4 mg, 0.0072 mmole) and N-hydroxy 
sulfosuccinimide sodium salt (1.6 mg, 0.0072 mmole), were added for preparation of the 
activated ester intermediate. After one hour, 2-mercaptoethanol (0.5 μL, 0.0072 mmole) was 
added with stirring for one minute. This latter step scavenges the unreacted EDC, which, if 
present, could cross-link with the protein resulting in unwanted conjugates in solution. 
Thyroglobulin (5 mg) was dissolved in 1 mL of a 0.25 M borate buffer (pH 8.8). The 
activated ester solution (0.6 mL) was added to the thyroglobulin (Thy) solution with rapid 
stirring. A similar procedure was followed for preparation of the coating antigen by 
conjugating hapten to BSA (dissolved 2.5 mg of BSA in 0.5 mL of borate buffer (pH 8.8)). 
Then, the activated ester solution (0.3 mL) was added to the BSA solution. The solutions 
were stirred at room temperature for 1.5 h, after which they were transferred to 4 °C for 
overnight incubation. Unreacted small molecules were removed by dialysis. The reaction 
mixtures containing the immunogen and coating antigen were dialyzed (10,000 MW cut-off) 
under stirring against PBS (0.01 M, pH 7.5), for 3 d, with frequent changing of the PBS 
solution to remove the unconjugated free hapten. Polyacrylamide gel electrophoresis and 
subsequent visualization with a SYPRO Ruby gel stain for glycoproteins showed that the 
haptens had coupled to the proteins. The resulting conjugates were stored at −20 °C for 
future use.
Immunization and Antiserum Preparation
The immunization procedure followed a previously published protocol.24,25 Three female 
New Zealand white rabbits M6122, M6123, M6124, were each immunized with 500 μg of 
immunogen hapten-Thy (concentration of 5 mg/mL) in the initial immunization (pre-
immune bleeds were collected from each rabbit prior to immunization). Following this, each 
rabbit received 300 μg of immunogen in the four subsequent boosts. A single test bleed was 
collected a month after the first immunization and two boosts separated by a one-week 
interval. A week after the test bleed collection, the third and fourth boosts were given, 
separated by a two-week interval. Production bleeds (20 mL from each rabbit) were 
collected in 3 months following the first immunization and all of the four boosts. Antiserum 
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(from the production bleed) was obtained by centrifugation, stored at −20 °C, and used 
without further purification.
Development of Indirect Competitive ELISA
Although there are several different configurations for competitive ELISAs, we chose to 
develop the ELISA using the antigen immobilization format, following a previously 
reported procedure. In this assay format, the coating antigen was directly immobilized on the 
ELISA plate. A fixed amount of unlabeled primary antibody and labeled secondary antibody 
(tracer) were added. This implies an indirect detection method, which is contrary to direct 
detection wherein an enzyme conjugated primary antibody is employed. Use of non-purified 
and a single antigen-specific primary antibody and commercial availability of a wide variety 
of labeled secondary antibodies are major advantages of the indirect ELISA approach. In the 
indirect method, the labeled secondary antibody binds to different epitopes (antigenic 
determinants) of the primary antibody, providing greater signal amplification than that can 
be achieved with the direct method. The indirect ELISA is competitive when it is based on 
competition between target analyte in the sample and the immobilized or the coating 
antigen-hapten for a fixed amount of the primary antibody. As the concentration of the target 
analyte increases, the amount of coated antigen captured by the primary antibody decreases.
Details of the ELISA procedure followed for the reported assay are given in the subsequent 
sections.
Standard Curve Preparation
To evaluate the sensitivity and range of linearity of the ELISA, standard curves of both 
target compounds 1 and 2 were prepared in a 10% DMSO (dimethyl sulfoxide)-PBS dilution 
buffer (final dilution in the plate wells being 5% DMSO-PBS). In addition to two negative 
controls (no antibody blank wells in PBS and no coating antigen wells in 5% DMSO-PBS), 
a positive control in 5% DMSO-PBS with zero standard analyte were chosen. Nine standard 
concentrations were prepared from a five-fold serial dilution of a 50,000 ng/mL preparation. 
The limit of detection, set as IC10, the assay sensitivity, represented by the IC50 value and 
the linear range of detection, set as IC20 – IC80, were obtained from the calibration curve 
data. The data were fitted to a four-parameter logistic equation, using Igor Pro 6.22A, 
Wavemetrics, Inc.
Cross-Reactivity Determination
ELISA plates were coated with coating antigen at 0.1 μg/mL in coating buffer (100 μL/well) 
by overnight incubation at 4 °C. The plates were washed five times with 1× PBS containing 
0.05% Tween 20. Plates were blocked for 0.5 h at room temperature with 1% BSA-PBS 
(350 μL/well) and washed five times. For the competitive inhibition, 50 μL/well of 
competing analytes (targets 1 and 2 and cross-reactants: hesperetin dihydrochalcone, 3; 
hesperetin dihydrochalcone 2′-glucoside, 5; phloretin, 4 and phloretin 2′-glucoside, 6, 
glucose and p-coumaric acid) were added starting at 50,000 ng/mL, followed by a five-fold 
serial dilution, ending at 0.128 ng/mL. Each ELISA plate had two competitors: target 1 and 
one cross-reactant, in two sets, with quadruplicate wells for each concentration. The 
competitor was co-incubated with 50 μL/well of primary antibody (at a dilution of 1 in 
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5000) for 1 h. After washing, secondary antibody, GAR-HRP, was added at a dilution of 1 
in 25000, followed by an hour of incubation. This was followed by a 5× wash and addition 
of 100 μL of a solution containing TMB and 1% H2O2 in citrate buffer in each well, yielding 
a blue color when oxidized. The plate was incubated for 15 minutes before the reaction was 
stopped by the addition of 50 μL of 1N H2SO4 in each well. The absorbances were recorded 
at 450 nm, with background subtraction at 650 nm. The cross reactivity was calculated as 
[(IC50 of target)/(IC50 of cross-reactant)] × 100.
Matrix Effect Determination
Two commonly used culture media, LB Broth and SOC, were used in these studies. Bacteria 
(E. coli K12 strain) were grown in each broth to an OD600 ≥ 4.0. The media was centrifuged 
and the supernatant was used for the matrix effect study. To determine interference effects 
from the matrix, neat fermentation media supernatant samples were spiked with the standard 
solution in 10% DMSO-PBS. Competitive curves with final concentrations of the target 
compounds 1 and 2 (five-fold serial dilution starting from 50,000 ng/mL to 0.128 ng/mL) 
were run in 5% DMSO-PBS (final dilution in plate wells) and in various dilutions of 
fermentation media (1:5, 1:20 and 1:100). IC50 values obtained from each diluted curve 
were compared with those generated from the assay buffer (5% DMSO-PBS).
RESULTS AND DISCUSSION
Rationale for Design of Hapten
Hapten 4-(3-oxo-3-(2,6-dihydroxy-4-glucoside phenyl) propyl)benzoic acid (Figure 1) was 
chosen for the competitive assay development. The hapten with a –COOH functional group 
conjugated to Thy, was designed for immunizing to raise antibodies. Immunizing haptens 
typically are a close structural mimic of the target analyte having a functional group that can 
be used to couple the hapten to a protein. The carboxylic acid substituted hapten was chosen 
because it would likely generate antibodies that will detect both compounds 1 and 2, but not 
3, 4, 5 and 6. The hapten was coupled to the protein at a point most distal to the sugar 
(providing discrimination between 2′- and 4′-glucosides) and close to the B phenyl ring 
farthest from the glycoside moiety, thus minimizing discrimination between compounds 1 
and 2 and at the same time, precluding antibody detection of the aglycones 3 and 4. In a 
competitive ELISA, the target analyte competes with the immobilized, coating antigen-
hapten for a fixed amount of antibody. The carboxylic acid group substituted hapten was 
used as both the immunogen and coating 3 antigen hapten in a homologous competitive 
ELISA format. In the following discussion, results are reported for the homologous ELISA 
developed with this hapten for target 1, with target 2 tested as a cross-reactant in the assay.
Antibody Characterization
Antisera collected from three rabbits M6122, M6123 and M6124 after the first immunization 
and two boosts separated by a one-week interval were subjected to titration by the 
homologous competitive ELISA. All three antisera showed significantly high titers (data not 
shown) indicative of the rabbits’ response to the immunogen. Checkerboard titrations 
(CBTs) were performed to determine the optimum concentrations of the antibody raised 
against hapten-Thy and coating antigen (hapten-BSA) with a 2-fold serial dilution of the 
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antibody, starting from a 1000× dilution up to a 128,000× dilution, screened against a five-
fold serial dilution of coating antigen (2 × 104 ng/mL to 1.3 ng/mL). The determined 
optimum concentrations of antibody and coating antigen in the assay had minimum 
variations among the three rabbits tested. The IC50 values obtained with antisera from 
rabbits M6123 and M6124, for target 1 as the inhibitor, were 243.8 and 114.5 ng/mL, 
respectively (Figure S5 in Supplementary Information). These values were at least an order 
of magnitude higher than that obtained with Ab M6122, demonstrating much lower assay 
sensitivities. Following this, the antisera obtained from rabbit M6122 was used for further 
immunoassay development. A CBT was performed with concentrations (250 ng/mL, 25 
ng/mL and 0 ng/mL) of the target analyte 1 with four different antisera dilutions 5000×, 
10,000×, 15,000× and 20,000× screened against a five-fold serial dilution of coating antigen 
concentrations (from 4000 ng/mL to 32 ng/mL). The combination of Ab M6122 and coating 
antigen, hapten-BSA that had over 80% inhibition at 250 ng/mL analyte concentration were 
screened using nine concentrations of target 1 ranging from 0.128 ng/mL to 5×104 ng/mL. 
This dilution series was also used to assess the linear range of the assay. Wells with zero 
coating antigen and with zero primary antibody served as the negative controls. Wells with 
zero analyte concentration served as the positive controls. For targets 1 and 2 as inhibitors in 
the assay, IC50 values of 27.8 and 21.8 ng/mL, respectively, were obtained (Figure 2).
Assay Optimization
The optimum concentrations of coating antigen hapten-BSA and Ab M6122 were 100 
ng/mL and 1:10,000 dilution in the well, respectively. Since both targets 1 and 2 were only 
partially soluble in water, a series of co-solvents were screened and DMSO was selected to 
improve solubility. PBS buffer containing DMSO at different concentrations was tested to 
assess changes in assay sensitivity. A reduction in the optical densities and a decrease in 
assay sensitivity were observed with increasing DMSO concentrations (Figure S6 in 
Supplementary Information). Thus, a 10% DMSO-PBS in 0.15 M PBS, pH 7.4 buffer was 
selected to prepare the standard solutions and spiked fermentation media samples for assay 
optimization. The linear range of detection was 2 –300 ng/mL. The fermentation media 
supernatant samples were diluted as necessary to stay within the linear range of detection. 
Intra- and inter-plate variations (assays run on the same day as well as on different days) 
were determined by calculating the percent coefficient of variation (% CV) in the assay for 
both 1 and 2 The % CV was < 10%, implying minimum variations between wells and 
limited day-to-day variability.
Cross-reactivity (CR)
In order to determine antibody selectivity, compounds 3-6 (Table 1) with structural 
similarity to targets 1 and 2 and which are probable metabolites or precursors to the target 
compounds in the microbial system of production were investigated for relative cross-
reactivity. With hapten-BSA as the competing coating antigen, the Ab M6122 showed 
>100% binding to target 2, phloretin 4′-glucoside (CR 127%, IC50 21.8 ng/mL). As 
expected, the antibody exhibited virtually no recognition of the aglycones hesperetin 
dihydrochalcone, 3 and phloretin, 4 because they do not inhibit even at 50,000 ng/mL. With 
the 2′-glucosides, the antibody exhibited a very low recognition of hesperetin 
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dihydrochalcone 2′-glucoside, 5 (CR 14%, IC50 202 ng/mL, an order of magnitude greater 
than that observed for target 1 with an IC50 of 27.8 ng/mL, indicating > 10× lower 
sensitivity). There was limited reactivity with phloridzin, 6 (CR <0.01%). Antisera obtained 
from rabbits M6123 and M6124 were also tested for cross-reactivity to hesperetin 
dihydrochalcone 2′-glucoside, 5 (see supplementary information Figure S2). Both antibodies 
displayed a very small level of cross-reactivity to 5, CR 15% for Ab M6123 and CR 21% for 
Ab M6124. Also, no cross-reactivity was observed with glucose and p-coumaric acid, other 
probable by-products in the microbial fermentation.
Matrix Effects
Variations in analyte reactivity in the presence of the matrix were tested by measuring the 
standard curves in fermentation media spiked with the target compounds 1 and 2. The 
standard curves in spiked fermentation media supernatant obtained at different dilutions of 
the media were compared with that obtained in the assay buffer (5% DMSO-PBS final 
dilution in wells). A difference in the values of percentages of control for the standard curve 
and corresponding dilution of the media (LB broth supernatant), observed at the IC50 value 
of the standard curve in 5% DMSO-PBS was taken as a measure to estimate the matrix 
effect. For target 1, at 1 in 5 and 1 in 20 dilutions of the media, a difference in the percents 
of control of 4.66 ± 1.68 and 5.74 ± 1.68, respectively, between the standard curves for 
assay buffer and spiked media were obtained. At a 1 in 100 dilution of the media, the 
standard curve of 1 (Figure 3) was parallel to the one in 5% DMSO-PBS buffer, with a 
much lower difference of 0.26 ± 1.68. Correspondingly, for target 2 (Figure 4), 6.47 ± 1.66 
at a 1 in 5 dilution and a difference of 0.5 ± 1.66 at a 1 in 20 dilution were observed, 
whereas at a 1 in 100 dilution, the difference was 1.5 ± 1.66. These small differences 
essentially signify absence of any matrix interference. Also, no matrix effect was observed 
with the SOC media supernatant at the tested dilutions (1 in 5, 1 in 25 and 1 in 125). For the 
recovery study, hesperetin dihydrochalcone-4′-glucoside, 1 dissolved in DMSO was spiked 
at 0.128-5×104 ng/mL in 10 μL of clear fermentation media supernatant, and analyzed in 
triplicate. Table 2 shows the mean percent recovery data for target 1, given for four different 
analyte concentrations. A recovery of > 80% points to minimal interference from the 
fermentation media.
In summary, the new competitive indirect, polyclonal antibody-based ELISA presented here 
was designed to serve as a class-selective immunoassay for the preferential detection of the 
target 4′-glucosides - hesperetin dihydrochalcone-4′-glucoside, 1 and phloretin-4′-glucoside, 
2. The homologous assay has IC50 values of 27.8 and 21.8 ng/mL for target compounds 1 
and 2, respectively. There are many criteria for successful production of a target compound 
by fermentation or other approaches, one of which is reasonable yield. For this work, we 
selected a concentration of ~ 1 mg/mL of the target compounds. This is considered as a 
reasonable minimum yield for the high throughput screening process using whole cells or 
purified enzyme. Thus, even with the necessary dilutions of the fermentation media to avoid 
matrix effects, the sensitivity of the assay is more than adequate for use in monitoring during 
optimization of fermentation conditions. The immunoassay can be utilized on-site, further 
reducing the time and cost of the optimization process. It can also be used for continued 
monitoring during production.
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Chemical structures of neohesperedin, a flavanone glycoside and the hapten 4-(3-oxo-3-
(2,6-dihydroxy-4-glucoside phenyl) propyl)benzoic acid.
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ELISA inhibition curves for target compounds A. hesperetin dihydrochalcone 4′-glucoside, 
1 and B. phloretin 4′-glucoside, 2. Each data point represents the mean of quadruplicates.
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Matrix effects evaluation for fermentation media supernatant (LB broth) spiked with target 
1, hesperetin dihydrochalcone 4′-glucoside. Each data point represents the mean of 
quadruplicates. The standard curve in 5% DMSO-PBS was generated by taking the average 
of values from 8 ELISA plates.
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Matrix effects evaluation for fermentation media supernatant (LB broth) spiked with target 
phloretin 4′-glucoside 2. Each data point represents the mean of quadruplicates. The 
standard curve in 5% DMSO-PBS was generated by taking the average of values from 3 
ELISA plates.
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 of Ab M6122 to structurally related compounds.














phloretin 2′-glucoside < 0.01
a
CR (%) was calculated as (IC50 of the target analyte/IC50 of the tested compound) × 100.
b
Not inhibited at 50,000 ng/mL. 3 experiments each with 4-well replicates.
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Table 2




Detected (ng/mL) Mean recovery (%) (SD)
2000 2747.3 137.4 (39.5)
400 384.9 96.2 (13.7)
80 67.5 84.3 (17.1)
16 16.2 100.8 (27.1)
a
Different amounts of hesperetin dihydrochalcone-4′-glucoside, 1 (in DMSO) were added to the fermentation media supernatant. The spiked media 
samples were diluted 100-fold with PBS (5% DMSO) (n = 3).
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